TCRT
Alaunos Therapeutics, Inc.
Key Financials
Net Income
$-4176000
↑ 10.8%
Operating Income
$-4225000
↑ 12.2%
Revenue
$5000
↓ 50.0%
EPS (Diluted)
$-2.20
↑ 24.7%
Cash & Equivalents
$1.4M
↑ 26.9%
Total Assets
$3.0M
↑ 7.7%
Shareholders' Equity
$2.2M
↑ 4.4%
Total Liabilities
$813000.00
↑ 17.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 10/13/2026 | View on SEC |
| 8-K | 10/9/2026 | View on SEC |
| 4 | 10/8/2026 | View on SEC |
| 4 | 10/8/2026 | View on SEC |
| 4 | 10/8/2026 | View on SEC |
| 4 | 10/8/2026 | View on SEC |
| 8-K | 9/22/2026 | View on SEC |
| 424B3 | 9/21/2026 | View on SEC |
| 8-K | 9/17/2026 | View on SEC |
| 10-Q | 8/14/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TCRT |
| Company Name | Alaunos Therapeutics, Inc. |
| CIK | 1107421 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (346) 355-4099 |